Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.

Tropical medicine & international health : TM & IH - 1 Mar 2023

Delaney Kayla Eileen, Ngobeni Trevor, Woods Conan K, Gordijn Carli, Claassen Mathilda, Parikh Urvi, Harrigan P Richard, van Zyl Gert Uves

Abstract excerpt

OBJECTIVES: Low-capital-layout sequencing options from Oxford Nanopore Technologies (ONT) could assist in expanding HIV drug resistance testing to resource-limited settings. HIV drug resistance mutations often occur as mixtures, but current ONT pipelines provide a consensus sequence only. Moreover, there is no integrated pipeline that provides a drug resistance report from an ONT sequence file without...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV/AIDS drug development and treatment

Share to HIV Infections

Share to HIV Seropositivity

Share to Mutation

Share to Nanopore Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 36599816
DOI: 10.1111/tmi.13851
PMCID: PMC10230441

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nano-RECall provides an integrated pipeline for HIV-1 drug resistance testing from Oxford Nanopore sequence data.PMID 36599816Read ↗

The utility of integrating nanopore sequencing into routine HIV-1 drug resistance surveillance.Semantic proximity Read ↗

From sequence data to patient result: a solution for HIV drug resistance genotyping with Exatype, end to end software for Pol-HIV-1 Sanger based Sequence analysis and patient HIV drug resistance result generationSemantic proximity Read ↗

From Sequence Data to Patient Result: A Solution for HIV Drug Resistance Genotyping With Exatype, End to End Software for Pol-HIV-1 Sanger Based Sequence Analysis and Patient HIV Drug Resistance Result Generation.Semantic proximity Read ↗

From sequence data to patient result: a solution for HIV drug resistance genotyping with Exatype, end to end software for Pol-HIV-1 Sequence analysis and patient HIV drug resistance result generationSemantic proximity Read ↗

Technologies for HIV-1 drug resistance testing: inventory and needs.Semantic proximity Read ↗

Leveraging the Oxford Nanopore MinION sequencing platform for HIV-1 drug resistance surveillance in resource-limited settings: a post-COVID implementation opportunity.Semantic proximity Read ↗

Portable Nanopore sequencing solution for next-generation HIV drug resistance testing.Semantic proximity Read ↗

HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance PipelineSemantic proximity Read ↗

G-HIV: An Integrated Long-Read Sequencing and Automated Bioinformatics Platform for Rapid and Precise HIV-1 SurveillanceSemantic proximity Read ↗

A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations.Semantic proximity Read ↗

HIV-DRIVES: HIV Drug Resistance Identification, Variant Evaluation, & Surveillance PipelineSemantic proximity Read ↗

Deep sequencing for HIV-1 clinical management.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.